FDA July 2026 Peptide Meeting: What Patients Need to Know About Access, Approval, and Safety Meto blog FDA takes first step in possible reversal of ban on some peptides The Washington Post Which non FDA (United States Food and Drug Administration) approved peptides, such as BPC 157 (Body Protection Compound 157) and TB 500 (Thymosin Beta 500), are likely legitimate for medical use under strict supervision? FDA considers adding a dozen peptides to its bulk drug compounding list RAPS In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion